Evidence map›Paper›PMID 28484681›Full record

ReviewCureus2017

Link Between Non-Alcoholic Fatty Liver Disease and Atrial Fibrillation: A Systematic Review and Meta-Analysis.

Abdul M Minhas, Muhammad Shariq Usman, Muhammad S Khan, Kaneez Fatima, Muhammad A Mangi, Michael A Illovsky

Open access · diamondAbstract readReview
In one paragraph

Review in Cureus, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 3 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 3 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Nonalcoholic fatty liver disease as a predictor of atrial fibrillation: a systematic review and meta-analysis.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Abdul M MinhasGME Internal Medicine, Orange Park Medical Center.
Muhammad Shariq UsmanMedical Student, Dow Medical College Karachi, Pakistan.
Muhammad S KhanInternal Medicine, John H Stroger J. Hospital of Cook County.
Kaneez FatimaCivil Hospital, Dow University of Health Sciences (DUHS), Karachi, Pakistan.
Muhammad A MangiInternal Medicine, Orange Park Medical Center.
Michael A IllovskyFirst Coast Cardiovascular Institute, Orange Park, Fl, Usa.
Orange (Poland) · PLCivil Hospital Karachi · PKDow University of Health Sciences · PKFirst Coast Cardiovascular Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Association between non-alcoholic fatty liver disease (NAFLD) and various cardiovascular diseases has been demonstrated previously. Recent clinical studies have shown that increased circulating levels of γ glutamyl transpeptidase and liver transaminase, markers which are elevated in NAFLD, increase the risk of new-onset atrial fibrillation. We conducted a systematic review and meta-analysis of the available evidence to establish the possible association of increased chances of atrial fibrillation in patients with NAFLD. We extensively searched the PubMed, EMBASE, Cochrane Library, ISI Web of Science and Scopus databases to identify all possible studies that investigated the possible association of NAFLD with atrial fibrillation. Random effect models were used to pool the data between NAFLD and non-NAFLD group. I

Indexed as

atrial fibrillationliver diseasemeta-analysisnafld

Identifiers

PMID28484681
PMCPMC5419817
OpenAlexW2604307570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.